Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality ¿cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)
Marcia Garnica; Edvan De Queiroz Crusoe; Glaciano Ribeiro; Rosane Bittencourt; Roberto José Pessoa Magalhães; Karla Richter Zanella; Abrahão Elias Hallack Neto; Juliana Souza Lima; Caroline Bonamin Solo; Emmanuella Graciott Souza; Andre Magalhaes Fernandes; Angelo Maiolino; Vania Hungria;
Hematol Transfus Cell Ther. 2024;46:153-60
Epidemiology and risk factors for the development of infectious complications in newly diagnosed multiple myeloma: a multicenter prospective cohort study in Uruguay
Eloísa Riva; David Garrido; Fiorella Villano; Virginia Bove;
Hematol Transfus Cell Ther. 2024;46:434-42
Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
Edvan de Queiroz Crusoé; Flávia Cristina Fernandes Pimenta; Angelo Maiolino; Nelson Siqueira de Castro; Huiling Pei; Damila Trufelli; Mariana Fernandez; Luciana Barreto Herriot;
Hematol Transfus Cell Ther. 2021;43:417-23